These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31002702)

  • 41. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission.
    Thompson KM; Duintjer Tebbens RJ
    BMC Infect Dis; 2015 Sep; 15():376. PubMed ID: 26382234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of HIV and antiretroviral drug exposure on lung growth and function over 2 years in an African Birth Cohort.
    Gray DM; Wedderburn CJ; MacGinty RP; McMillan L; Jacobs C; Stadler JAM; Hall GL; Zar HJ
    AIDS; 2020 Mar; 34(4):549-558. PubMed ID: 31714357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth.
    Linder N; Handsher R; German B; Sirota L; Bachman M; Zinger S; Mendelson E; Barzilai A
    Arch Dis Child Fetal Neonatal Ed; 2000 Jul; 83(1):F24-7. PubMed ID: 10873167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
    Sarnquist C; Holubar M; García-García L; Ferreyra-Reyes L; Delgado-Sánchez G; Cruz-Hervert LP; Montero-Campos R; Altamirano J; Purington N; Boyle S; Modlin J; Ferreira-Guerrero E; Canizales-Quintero S; Díaz Ortega JL; Desai M; Maldonado YA
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S115-S120. PubMed ID: 30376084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.
    Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA
    Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
    HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)-Unexposed and HIV-Exposed, Uninfected South African Children.
    Mutsaerts EAML; Nunes MC; Bhikha S; Ikulinda BT; Boyce W; Jose L; Koen A; Moultrie A; Cutland CL; Grobbee DE; Klipstein-Grobusch K; Madhi SA
    J Infect Dis; 2019 Sep; 220(9):1529-1538. PubMed ID: 31282539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Epidemiological characteristics of HIV infected pregnant women and exposed infants in Guangdong province, 2014-2017].
    Tang LY; Zhang CB; Gao S; Wang ZQ; Miao HZ; Xia JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1392-1397. PubMed ID: 31838810
    [No Abstract]   [Full Text] [Related]  

  • 50. Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman.
    Sutter RW; Suleiman AJ; Malankar PG; Mehta FR; Medany MA; Arif MA; Linkins RW; Pallansch MA; El-Bualy MS; Robertson SE
    J Infect Dis; 1997 Feb; 175 Suppl 1():S235-40. PubMed ID: 9203722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.
    Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA
    Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.
    Slogrove AL; Esser MM; Cotton MF; Speert DP; Kollmann TR; Singer J; Bettinger JA
    Pediatr Infect Dis J; 2017 Feb; 36(2):e38-e44. PubMed ID: 28081048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants.
    Nunes MC; Cutland CL; Dighero B; Bate J; Jones S; Hugo A; van Niekerk N; Kuwanda L; Izu A; Weinberg A; Madhi SA;
    J Infect Dis; 2015 Dec; 212(12):1976-87. PubMed ID: 26080370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants.
    Church JA; Rukobo S; Govha M; Carmolli MP; Diehl SA; Chasekwa B; Ntozini R; Mutasa K; Humphrey JH; Kirkpatrick BD; Prendergast AJ
    Trans R Soc Trop Med Hyg; 2019 Mar; 113(3):110-115. PubMed ID: 30576507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1.
    Ryder RW; Oxtoby MJ; Mvula M; Batter V; Baende E; Nsa W; Davachi F; Hassig S; Onorato I; Deforest A
    J Pediatr; 1993 May; 122(5 Pt 1):697-702. PubMed ID: 8496745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trial of a supplemental dose of four poliovirus vaccines.
    Sutter RW; Suleiman AJ; Malankar P; Al-Khusaiby S; Mehta F; Clements GB; Pallansch MA; Robertson SE
    N Engl J Med; 2000 Sep; 343(11):767-73. PubMed ID: 10984564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
    Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors associated with non-attendance at scheduled infant follow-up visits in an observational cohort of HIV-exposed infants in South Africa, 2012-2014.
    Ngandu NK; Jackson D; Lombard C; Nsibande DF; Dinh TH; Magasana V; Mogashoa M; Goga AE
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):788. PubMed ID: 31526372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children who missed routine programme.
    Andrianarivelo MR; Boisier P; Rabarijaona L; Ratsitorahina M; Migliani R; Zeller H
    Trop Med Int Health; 2001 Dec; 6(12):1032-9. PubMed ID: 11737841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.